Skip to main content
Market intelligence
PTCTHealthcare

PTC Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 20, 2026Michael SchmertzlerDirectorSale25,000$72.22$1,805,413
Aug 17, 2026Mark Elliott BouldingEXEC. VP AND CLOSale2,813$72.57$204,127
Aug 4, 2026Matthew B. KleinCHIEF EXECUTIVE OFFICERSale10,292$68.57$705,722